santé
The Slovak Spectator | 7-mar-2018
Slovakia will no longer have to compensate Achmea B.V., the shareholder of Union ZP health insurer, for €22 million in damage.
Franceinfo | 5-déc-2017
Comment la simple menace d’un arbitrage international peut suffire à dissuader un pays de s’opposer aux intérêts d’une multinationale, c’est le "chilling effect".
Harvard International Law Journal | 26-oct-2017
On July 2016, a Partial Award dismissed the Renco Group Inc. v. The Republic of Peru case, indicating, however, that a new arbitration claim could be pursued against the State.
People over Profit | 7-sep-2017
Philippine civil society groups and social movements stand together to oppose RCEP
BBC | 10-jui-2017
Tobacco giant Philip Morris has been ordered to pay the Australian government millions of dollars after unsuccessfully suing the nation over its world-first plain-packaging laws.
IP Watch | 28-avr-2017
Although Canada won in a unanimous decision, the ruling does not, however, guarantee domestic discretion going forward, contrary to the suggestion of some.
Global Justice Now | 24-avr-2017
A new briefing has outlined the likely elements of a UK-US trade deal and argues that it would contain more extreme forms of all the controversial elements of the deal that was being negotiated between the EU and the USA.
Mots-clés:
climat ,
États-Unis d’Amérique ,
litiges investisseurs-état | ISDS,
Royaume uni ,
santé ,
services
Tech Dirt | 21-avr-2017
ISDS is an attempt to remove the risk of investment from companies, and place it squarely on the public’s shoulders, without any quid pro quo.
Public Citizen | 1er-avr-2017
Novartis battle against Colombian Government highlights the threats to public health posed by the outrageous investor-state dispute settlement regime and bad “trade” deals.
Tech Dirt | 22-mar-2017
Just the fact that the Canadian government had to go through this massive and expensive process for many years just for rejecting two bad patents should show why ISDS provisions are such a problem.
0 | ... | 50 | 60 | 70 | 80 | 90 | 100 | 110 | 120 | 130 | ... | 150
